Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BTSG
BTSG logo

BTSG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brightspring Health Services Inc (BTSG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
41.330
1 Day change
-0.02%
52 Week Range
44.870
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

BrightSpring Health Services Inc (BTSG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and growth potential outweigh the minor short-term price fluctuations.

Technical Analysis

The technical indicators for BTSG are generally bullish. The MACD histogram is positive and expanding, indicating upward momentum. The RSI is neutral at 61.025, and the moving averages (SMA_5 > SMA_20 > SMA_200) confirm a bullish trend. Key support is at 39.47, and resistance is at 43.848, suggesting the current price is near a potential buying opportunity.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
7

Positive Catalysts

  • Analysts have consistently raised price targets, with the latest targets ranging from $46 to $55, reflecting strong growth expectations.

  • The company reported a 29% YoY revenue increase in Q4 2025 and a 381.78% YoY net income growth, showcasing robust financial performance.

  • Recent acquisitions, such as Amedisys and LHC assets, are expected to drive future growth.

  • The company has announced a share repurchase program, which is often seen as a sign of confidence in the stock's value.

Neutral/Negative Catalysts

  • The stock recently experienced a secondary offering, which can dilute existing shareholders' value.

  • Gross margin decreased by 15.92% YoY in Q4 2025, which could be a concern for profitability.

  • Short-term price volatility is evident, with a -0.45% regular market change and a -2.35% post-market change.

Financial Performance

In Q4 2025, BrightSpring Health Services reported strong financial results: Revenue increased by 16.31% YoY to $3.55 billion, Net Income surged by 381.78% YoY to $77.08 million, and EPS grew by 325% YoY to 0.34. However, gross margin declined by 15.92% YoY to 11.62%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive on BTSG, with multiple firms raising price targets recently. The updated price targets range from $46 to $55, with ratings such as Overweight, Outperform, and Buy. Analysts cite strong growth momentum, successful acquisitions, and durable business strategies as key drivers for their optimism.

Wall Street analysts forecast BTSG stock price to rise
12 Analyst Rating
Wall Street analysts forecast BTSG stock price to rise
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 41.340
sliders
Low
40
Averages
43.2
High
50
Current: 41.340
sliders
Low
40
Averages
43.2
High
50
Morgan Stanley
NULL -> Overweight
maintain
$40 -> $48
AI Analysis
2026-03-04
Reason
Morgan Stanley
Price Target
$40 -> $48
AI Analysis
2026-03-04
maintain
NULL -> Overweight
Reason
Morgan Stanley raised the firm's price target on BrightSpring Health to $48 from $40 and keeps an Overweight rating on the shares. The firm update its model post-Q4 earnings to reflect the Amedisys/LHC acquisition in the Provider Services segment.
Mizuho
Outperform
maintain
$45 -> $50
2026-03-03
Reason
Mizuho
Price Target
$45 -> $50
2026-03-03
maintain
Outperform
Reason
Mizuho raised the firm's price target on BrightSpring Health to $50 from $45 and keeps an Outperform rating on the shares. The firm updated the company's model post the "solid" Q4 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BTSG
Unlock Now

People Also Watch